Roquefort Therapeutics "seeing good results" across several therapeutics
News release
by
Roquefort Therapeutics PLC
London, UK
|
June 27, 2023 08:32 AM Eastern Daylight Time
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Thomas Warner from Proactive following a flurry of announcements from the biotech company. Reginald gives an overview of three recent developments, including the results of trials into treatments for osteosarcoma and Midkine-expressing cancers. He also highlights recent increases in the level of investment in the company by himself and by executive chairman Stephen West.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
